Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
RIBOSE (PYRANOSE)
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RIBOSE (PYRANOSE)
×
Maximum Phase:
2
First Approval:
None
UNII:
49X539P7H4
Molecule Type:
Small molecule
Molecular Formula:
C5H10O5
Molecular Weight:
150.13
AlogP:
-2.58
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
CEDIROGANT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CEDIROGANT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BATABULIN SODIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BATABULIN SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
G04B77F772
Molecule Type:
Small molecule
Molecular Formula:
C13H6F6NNaO3S
Molecular Weight:
393.24
AlogP:
3.33
PSA:
55.4
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ROPSACITINIB
(2)
Small molecule
Tyrosine-protein kinase TYK2 inhibitor
Unknown
Investigational
Unknown
ROPSACITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
HY5SOV7O0Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17N9
Molecular Weight:
383.42
AlogP:
2.54
PSA:
113.41
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TIGOZERTINIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TIGOZERTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISOCTRIZOLE
(2)
Small molecule
Sunscreen
Unknown
Investigational
Unknown
BISOCTRIZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
8NT850T0YS
Molecule Type:
Small molecule
Molecular Formula:
C41H50N6O2
Molecular Weight:
658.89
AlogP:
9.58
PSA:
101.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
O-(2-FLUOROETHYL)-L-TYROSINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
O-(2-FLUOROETHYL)-L-TYROSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
P6VBV68WPV
Molecule Type:
Small molecule
Molecular Formula:
C11H14FNO3
Molecular Weight:
227.24
AlogP:
0.99
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
6.0
Source:
AZD-7268
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AZD-7268
×
Maximum Phase:
2
First Approval:
None
UNII:
958Y70F3HQ
Molecule Type:
Small molecule
Molecular Formula:
C29H30N4O2S
Molecular Weight:
498.65
AlogP:
4.85
PSA:
69.56
HBD:
1.0
HBA:
#RotB:
7.0
Source:
KRN5500
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
KRN5500
×
Maximum Phase:
2
First Approval:
None
UNII:
8VH13L5K20
Molecule Type:
Small molecule
Molecular Formula:
C28H43N7O7
Molecular Weight:
589.69
AlogP:
0.42
PSA:
214.84
HBD:
8.0
HBA:
#RotB:
17.0
Source:
SUVECALTAMIDE
(2)
Small molecule
Voltage-gated T-type calcium channel modulator
Unknown
Investigational
Unknown
SUVECALTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
MIA4WMP8QN
Molecule Type:
Small molecule
Molecular Formula:
C20H23F3N2O2
Molecular Weight:
380.41
AlogP:
4.57
PSA:
51.22
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BALIPODECT
(2)
Small molecule
Phosphodiesterase 10A inhibitor
Unknown
Investigational
Unknown
BALIPODECT
×
Maximum Phase:
2
First Approval:
None
UNII:
6650W303H0
Molecule Type:
Small molecule
Molecular Formula:
C23H17FN6O2
Molecular Weight:
428.43
AlogP:
3.42
PSA:
79.76
HBD:
0.0
HBA:
#RotB:
5.0
Source:
AROPLATIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AROPLATIN
×
Maximum Phase:
2
First Approval:
None
UNII:
J7M4Z2D183
Molecule Type:
Small molecule
Molecular Formula:
C26H52N2O4Pt
Molecular Weight:
651.79
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EBVACICLIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EBVACICLIB
×
Maximum Phase:
2
First Approval:
None
UNII:
3B512HJD65
Molecule Type:
Small molecule
Molecular Formula:
C20H27F2N5O4S
Molecular Weight:
471.53
AlogP:
2.04
PSA:
117.42
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DIEPALRESTAT CHOLINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DIEPALRESTAT CHOLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
16AHE7410O
Molecule Type:
Small molecule
Molecular Formula:
C35H39N3O7S4
Molecular Weight:
741.98
AlogP:
2.92
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZD1305
(2)
Small molecule
HERG blocker
Unknown
Investigational
Unknown
AZD1305
×
Maximum Phase:
2
First Approval:
None
UNII:
CZO834LXQM
Molecule Type:
Small molecule
Molecular Formula:
C22H31FN4O4
Molecular Weight:
434.51
AlogP:
1.99
PSA:
87.06
HBD:
1.0
HBA:
#RotB:
7.0
Source:
OLACAFTOR
(2)
Small molecule
Cystic fibrosis transmembrane conductance regulator positive modulator
Unknown
Investigational
Unknown
OLACAFTOR
×
Maximum Phase:
2
First Approval:
None
UNII:
RZ7027HK8F
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN3O4S
Molecular Weight:
539.67
AlogP:
5.67
PSA:
88.6
HBD:
1.0
HBA:
#RotB:
8.0
Source:
APRATASTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
APRATASTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
C6BZ5263BJ
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O6S2
Molecular Weight:
414.51
AlogP:
0.45
PSA:
116.17
HBD:
3.0
HBA:
#RotB:
5.0
Source:
GLYCIDIDAZOLE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GLYCIDIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
B2PT4D6Q3B
Molecule Type:
Small molecule
Molecular Formula:
C18H23N7O10
Molecular Weight:
497.42
AlogP:
-0.31
PSA:
215.06
HBD:
1.0
HBA:
#RotB:
14.0
Source:
4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE
(2)
Small molecule
DNA disrupting agent
Unknown
Investigational
Unknown
4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1S83F4T2WE
Molecule Type:
Small molecule
Molecular Formula:
C35H48Cl5NO4
Molecular Weight:
724.04
AlogP:
12.15
PSA:
57.65
HBD:
0.0
HBA:
#RotB:
8.0
Source:
MK-1029
(2)
Small molecule
G protein-coupled receptor 44 antagonist
Unknown
Investigational
Unknown
MK-1029
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BREQUINAR SODIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BREQUINAR SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECARFARIN SODIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TECARFARIN SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
G7MLG4D955
Molecule Type:
Small molecule
Molecular Formula:
C21H13F6NaO5
Molecular Weight:
482.31
AlogP:
5.13
PSA:
76.74
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DIPRAGLURANT
(2)
Small molecule
Metabotropic glutamate receptor 5 modulator
Unknown
Investigational
Unknown
DIPRAGLURANT
×
Maximum Phase:
2
First Approval:
None
UNII:
CV8JZR21A1
Molecule Type:
Small molecule
Molecular Formula:
C16H12FN3
Molecular Weight:
265.29
AlogP:
2.85
PSA:
30.19
HBD:
0.0
HBA:
#RotB:
2.0
Source:
LAZUCIRNON
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LAZUCIRNON
×
Maximum Phase:
2
First Approval:
None
UNII:
R0T9LLR4TN
Molecule Type:
Small molecule
Molecular Formula:
C27H34ClN5O3
Molecular Weight:
512.05
AlogP:
3.65
PSA:
85.85
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ENPATORAN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ENPATORAN
×
Maximum Phase:
2
First Approval:
None
UNII:
7CZ390V26X
Molecule Type:
Small molecule
Molecular Formula:
C16H15F3N4
Molecular Weight:
320.32
AlogP:
2.82
PSA:
65.94
HBD:
1.0
HBA:
#RotB:
1.0
Source:
LY377604
(2)
Small molecule
Beta-1 adrenergic receptor antagonist
Unknown
Investigational
Unknown
LY377604
×
Maximum Phase:
2
First Approval:
None
UNII:
OCC6TB3P6K
Molecule Type:
Small molecule
Molecular Formula:
C31H32N4O4
Molecular Weight:
524.62
AlogP:
4.96
PSA:
122.49
HBD:
4.0
HBA:
#RotB:
11.0
Source:
AZD-6482
(2)
Small molecule
PI3-kinase class I inhibitor
Unknown
Investigational
Unknown
AZD-6482
×
Maximum Phase:
2
First Approval:
None
UNII:
78G6MP5PZ5
Molecule Type:
Small molecule
Molecular Formula:
C22H24N4O4
Molecular Weight:
408.46
AlogP:
2.71
PSA:
96.17
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PSILOCYBINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PSILOCYBINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2RV7212BP0
Molecule Type:
Small molecule
Molecular Formula:
C12H17N2O4P
Molecular Weight:
284.25
AlogP:
1.74
PSA:
85.79
HBD:
3.0
HBA:
#RotB:
5.0
Source:
VARESPLADIB
(2)
Small molecule
Phospholipase A2 group IIA inhibitor
Unknown
Investigational
Unknown
VARESPLADIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2Q3P98DATH
Molecule Type:
Small molecule
Molecular Formula:
C21H20N2O5
Molecular Weight:
380.4
AlogP:
2.38
PSA:
111.62
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ATABECESTAT
(2)
Small molecule
Beta-secretase 1 inhibitor
Unknown
Investigational
Unknown
ATABECESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
2834W8D6GK
Molecule Type:
Small molecule
Molecular Formula:
C18H14FN5OS
Molecular Weight:
367.41
AlogP:
3.14
PSA:
104.16
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ETHER
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ETHER
×
Maximum Phase:
2
First Approval:
None
UNII:
0F5N573A2Y
Molecule Type:
Small molecule
Molecular Formula:
C4H10O
Molecular Weight:
74.12
AlogP:
1.04
PSA:
9.23
HBD:
0.0
HBA:
#RotB:
2.0
Source:
GLYCOVIR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GLYCOVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
QXJ91425UL
Molecule Type:
Small molecule
Molecular Formula:
C26H45NO8
Molecular Weight:
499.65
AlogP:
3.95
PSA:
108.44
HBD:
0.0
HBA:
#RotB:
16.0
Source:
VOCACAPSAICIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VOCACAPSAICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
KRJ8H9BOG7
Molecule Type:
Small molecule
Molecular Formula:
C26H41N3O4
Molecular Weight:
459.63
AlogP:
4.66
PSA:
79.9
HBD:
2.0
HBA:
#RotB:
12.0
Source:
DAZCAPISTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DAZCAPISTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PINOCEMBRIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PINOCEMBRIN
×
Maximum Phase:
2
First Approval:
None
UNII:
8T7C8CH791
Molecule Type:
Small molecule
Molecular Formula:
C15H12O4
Molecular Weight:
256.26
AlogP:
2.8
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BELNACASAN
(2)
Small molecule
Caspase-1 inhibitor
Unknown
Investigational
Unknown
BELNACASAN
×
Maximum Phase:
2
First Approval:
None
UNII:
00OLE78529
Molecule Type:
Small molecule
Molecular Formula:
C24H33ClN4O6
Molecular Weight:
509.0
AlogP:
1.85
PSA:
140.06
HBD:
3.0
HBA:
#RotB:
7.0
Source:
1
2
…
122
123
124
125
126
127
128
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA